Latest Cystic fibrosis Stories
RICHMOND, Va., Jan.
VERONA, Italy, January 15, 2015 /PRNewswire/ -- CROMSOURCE, an international provider of outsourced services to the pharmaceutical, biotechnology and medical device industries,
Study Does Not Meet Primary Endpoint SOUTH SAN FRANCISCO, Calif., Jan. 6, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc.
Global Cystic Fibrosis Market 2015-2019 is a new industry research report which profiles key players like Actavis, Novartis, Gilead Sciences, Vertex Pharmaceuticals and F Hoffmann-La Roche.
BOULDER, Colo., Dec. 22, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
SOUTH PLAINFIELD, N.J., Dec. 19, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (Nasdaq: PTCT) today announced that both the U.S.
RICHMOND, Va., Dec.
Live and Interactive Webcast Presentation on Thursday, December 4 at 11:30 a.m. EST NORWOOD, Mass., Dec.
HAYWARD, Calif., Nov. 20, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc.
BOULDER, Colo., Nov. 19, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...
- Withering but not falling off, as a blossom that persists on a twig after flowering.